Thank you to Fierce Pharma and to Jacob Petersen, Kristen Fortney, Narimon Honarpour, and Darren Incorvaia, Ph.D
But getting access to them safely, affordably, and with proper medical oversight has always been the challenge
For people with diabetes, hypertension and a high risk of atherosclerotic CV disease (10-year risk greater than 15%), a blood pressure target of less than 130/80 mmHg is suggested
GLP-1 drugs, a class of obesity and diabetes medications that includes Ozempic, Wegovy, Zepbound, and Mounjaro, are known to produce significant weight loss
The levels of incretins including glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic hormone rise in response to a meal, and they are rapidly degraded by the enzyme dipeptidyl peptidase 4 (DPP-4) [5]